Author:
Manaspon Chawan,Nasongkla Norased,Chaimongkolnukul Khuanjit,Nittayacharn Pinunta,Vejjasilpa Ketpat,Kengkoom Kanchana,Boongird Atthaporn,Hongeng Suradej
Funder
Mahidol University
Royal Golden Jubilee Ph.D. Program
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference51 articles.
1. Joo YN, Eun SY, Park SW, Lee JH, Chang KC, Kim HJ. Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition. Int J Oncol. 2014;44(1):187–94.
2. Manaspon C, Hongeng S, Boongird A, Nasongkla N. Preparation and in vitro characterization of SN‐38‐loaded, self‐forming polymeric depots as an injectable drug delivery system. J Pharm Sci. 2012;101(10):3708–17.
3. Wang W, Ghandi A, Liebes L, Louie SG, Hofman FM, Schönthal AH, et al. Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo: Laboratory investigation. J Neurosurg. 2011;114(3):689–94.
4. Mathijssen RH, Van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res. 2001;7(8):2182–94.
5. Ramasamy T, Choi JY, Cho HJ, Umadevi SK, Shin BS, Choi H-G, et al. Polypeptide-based micelles for delivery of irinotecan: physicochemical and in vivo characterization. Pharm Res. 2015;32(6):1947–56.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献